Abstract
Porto-caval shunting has consistently been found to be the most effective treatment to prevent variceal bleeding. Shunting has over other treatments the advantage of normalizing portal pressure, which relieves and/or prevents not only rebleeding but also the other complications of portal hypertension. Surgical techniques can be classified into three main categories: shunting techniques either total or selective, selective variceal decompression, and devascularization procedures. As a whole, shunting was more effective than alternative treatments in preventing rebleeding, though survival was not improved and the incidence of HE was increased.
Surgical shunting has been virtually abandoned because of the development of interventional radiology techniques, mainly trans-jugular intrahepatic porto-systemic shunt (TIPS).
Whenever possible, liver transplantation should be considered in these patients whose liver function is usually poor. When it is contraindicated as well as in patients on the waiting list, or the few whose liver function is fairly preserved, a shunting procedure should be considered.
Nowadays, whenever a shunting procedure is considered needed, TIPS with PTFE-covered stents should be preferred to surgery because it avoids the complications of laparotomy, it does not hamper the chance for transplantation, and it can be reduced in diameter or occluded if needed because of the occurrence of refractory hepatic encephalopathy. Only in the few situations where TIPS cannot be performed, e.g., complete portal vein obstruction or cavernoma, devascularization techniques can be attempted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–9.
D’Amico G, De Franchis R, A cooperative study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599–612.
De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5:645–63.
D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–54.
Jackson FC, Perrin EB, Felix RW, Smith AG. A clinical investigation of the portacaval shunt: survival analysis of the therapeutic operation. Ann Surg. 1971;174:672–701.
Resnick RH, Iber FL, Ishiara A, Chalmers T, Zimmermann H, The Boston Inter-Hospital Liver Group. A controlled study of the therapeutic portacaval shunt. Gastroenterology. 1974;67:843–57.
Rueff B, Prandi D, Sicot J, Degos JP, Sicot C, Maillard JN, et al. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet. 1976;2:655–9.
Reynolds TB, Donovan AJ, Mikkelsen WP, Redeker AJ, Turril FL, Weiner JM. Results of a 12-year randomized trial of portacaval shunt in patients with a alcoholic liver disease and bleeding varices. Gastroenterology. 1981;80:1005–11.
Mehigan DG, Zuidema GD, Cameron JL. The incidence of shunt occlusion following portosystemic decompression. Surg Gynecol Obstet. 1980;150:661–3.
Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters: clinical and hemodynamic perspectives. Ann Surg. 1986;204:356–63.
Bismuth H, Franco D, Hepp I. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg. 1974;179:209–18.
Inokuchi K, Beppu K, Koyanagi N, Nagamine K, Hashizume M, Iwanaga T, et al. Fifteen years’ experience with left gastric venous caval shunt for esophageal varices. World J Surg. 1984;8:716–21.
Inokuchi K, Cooperative Study Group of Portal Hypertension in Japan. Improved survival after prophylactic portal non decompressive surgery for esophageal varices. Hepatology. 1990;12:1–6.
Boerema I, Klopper PJ, Holscher AA. Transabdominal ligation-resection of the esophagus in cases of bleeding esophageal varices. Surgery. 1970;67:409–13.
Prioton JB, Feneyrou B, Michel H, Bories P, Bertrand L, Blanc F. Long term results after portal disconnection of the esophagus using an anastomotic button for bleeding esophageal varices in cirrhosis. Surg Gynecol Obstet. 1986;163:121–6.
Walker RM. Esophageal transection for bleeding varices. Surg Gynecol Obstet. 1964;118:323–9.
Tanner NC. Direct operations in the treatment of complications of portal hypertension. J Int Coll Surg. 1961;36:308–14.
Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg. 1973;66:677–85.
Rikkers LF, Rudman D, Galambos JT, Fulenwider JT, Millikan WJ, Kutner M, et al. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg. 1978;188:271–82.
Reichle FA, Fahmy WF, Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg. 1979;137:13–21.
Fischer JE, Bower RH, Atamian S, Welling R. Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg. 1981;194:531–44.
Langer B, Taylor BR, Mackenzie DR, Gilas T, Stone RM, Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology. 1985;88:424–9.
Millikan WJ, Warren WD, Henderson JM, Smith III RB, Salam AA, Galambos JT, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg. 1985;201:712–22.
Harley HA, Morgan T, Redeker AG, Reynolds TB, Villamil F, Weiner JM, et al. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology. 1986;91:802–9.
Grace ND, Conn HO, Resnick RH, Groszmann RJ, Atterbury CE, Wright SC, et al. Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology. 1988;8:1475–81.
Rikkers LF, Burnett DA, Volentine GD, Buchi KN, Cormier RA. Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg. 1987;206:261–71.
Terés J, Bordas JM, Bravo D, Visa J, Grande L, Garcia-Valdecasas JC, et al. Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology. 1987;7:430–6.
Henderson JM, Kutner MH, Millikan Jr WJ, Galambos JT, Riepe SP, Brooks WS, et al. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med. 1990;112:262–9.
Planas R, Boix J, Broggi M, Cabré E, Gomes-Vieira MC, Morillas R, et al. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1991;100:1078–86.
Orozco H, Mercado MA, Chan C, Guillén-Navarro E, López-Martínez LM. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years. Ann Surg. 2000;232:216–9.
Isaksson B, Jeppsson B, Bengtsson F, Hannesson P, Herlin P, Bengmark S. Mesocaval shunt or repeated sclerotherapy: effects on rebleeding and encephalopathy–a randomized trial. Surgery. 1995;117:498–504.
Santambrogio R, Opocher E, Costa M, Bruno S, Ceretti AP, Spina GP. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past. World J Gastroenterol. 2006;12:6331–8.
Khan SA, Tudur Smith C, Williamson PR, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis (review). Cochrane Database Syst Rev. 2006;4, CD000553.
Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92:1112–4.
Colapinto RF, Stronell RD, Gildiner M, Ritchie AC, Langer B, Taylor BR, et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. Am J Roentgenol. 1983;140:709–14.
Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portacaval shunt stents: early experience in the dog. Am J Roentgenol. 1985;145:821–5.
Richter GM, Noeldge G, Palmaz JC, Roessle M, Slegerstetter V, Franke M, et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology. 1990;174:1027–30.
Otal P, Smayra T, Bureau C, Peron JM, Chabbert V, Chemla P, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. Am J Roentgenol. 2002;178:141–7.
Bureau C, Garcia-pagan JC, Otal P, Pomier-layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–75.
Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27:742–7.
Perelló A, García-Pagán JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132–9.
Blum U, Haag K, Rössle M, Ochs A, Gabelmann A, Boos S, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 1995;195:153–7.
Barton RE, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS: short- and long-term results: a survey of 1750 patients. Semin Intervent Radiol. 1995;12:364–7.
Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver. 1998;18:73–89.
Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron JM, Pierragi MT, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology. 1997;25:1064–9.
Bureau C, Otal P, Chabbert V, Péron JM, Rousseau H, Vinel JP. Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent. Hepatology. 2002;36:1554.
Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology. 1998;115:110–5.
Maleux G, Verslype C, Heye S, Wilms G, Marchal G, Nevens F. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts. Am J Roentgenol. 2007;188:659–64.
Sanyal AJ, Freedman AM, Purdum III PP. TIPS-associated hemolysis and encephalopathy. Ann Intern Med. 1992;117:443–4.
Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1996;110:832–9.
Sanyal AJ, Freedman AM, Velimir A, Purdum III PP, Shiffman ML, Cole PE, et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized controlled trial. Ann Intern Med. 1997;126:849–57.
Cello JP, Ring EJ, Olcott EW, Koch J, Gordon E, Sandhu J, et al. Endoscopic sclerotherapy compared with percutaneaous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized controlled trial. Ann Intern Med. 1997;126:858–65.
Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology. 1998;27:40–5.
Garcia-Villareal L, Martinez-Lagares F, Sierra A, Guevara C, Marrero JM, Jimenez E, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology. 1999;29:27–32.
Narahara Y, Kanazawa H, Kawamata H, Tada N, Saitoh H, Matsuzaka S, et al. A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res. 2001;21:189–98.
Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology. 1997;26:1115–22.
Pomier-Layrargues G, Villeneuve JP, Deschenes M, Bui B, Perreault P, Fenyves D, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut. 2001;48:390–6.
Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy. 2002;34:690–7.
Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, et al. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Scand J Gastroenterol. 2002;37:338–43.
Groupe d’Etude des Anastomoses Intra-Hépatiques. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial (abstract). Hepatology. 1995;22:A297.
Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding. Gastroenterology. 1997;113:1623–31.
Rössle M, Deibert P, Haag K, Ochs A, Olschweski M, Siegerstetter V, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997;249:1043–9.
Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Mointinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002;35:385–92.
Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portoystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology. 1999;30:612–22.
Luca A, D’Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology. 1999;212:411–21.
Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol. 2002;37:249–52.
Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg. 1996;224:378–84.
Rosemurgy AS, Serafini FM, Zweibel BR, Black TJ, Kudryk BT, Nord HJ, et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg. 2000;4:589–97.
Rosemurgy AS, Bloomston M, Clark WC, Thometz DP, Zervos EE. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg. 2005;241:238–46.
Rosemurgy AS, Frohman HA, Teta AF, Luberice K, Ross SB. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg. 2012;214:445–53.
Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643–51.
Rubenstein JH, Eisen GM, Inadomi JM. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol. 2004;99:1274–88.
Russo MW, Zacks SL, Sandler RS, Brown RS. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology. 2000;31:358–63.
Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol. 2008;48:407–14.
Ingrand P, Gournay J, Bernard P, Oberti F, Bernard-Chabert B, Pauwels A, et al. Management of digestive bleeding related to portal hypertension in cirrhotic patients: a French multicenter cross-sectional practice survey. World J Gastroenterol. 2006;12:7810–4.
de Franchis R, Faculty BV. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bureau, C., Vinel, JP. (2014). Role of TIPS and Surgery in Prevention of Rebleeding. In: de Franchis, R., Dell’Era, A. (eds) Variceal Hemorrhage. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0002-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0002-2_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0001-5
Online ISBN: 978-1-4939-0002-2
eBook Packages: MedicineMedicine (R0)